The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Exploitation of Long-Lived 3IL Excited States for Metal–Organic Photodynamic Therapy: Verification in a Metastatic Melanoma Model
Abstract
Members of a family of Ru(II)-appended pyrenylethynylene dyads were synthesized, characterized according to their photophysical and photobiological properties, and evaluated for their collective potential as photosensitizers for metal-organic photodynamic therapy. The dyads in this series possess lowest-lying (3)IL-based excited states with lifetimes that can be tuned from 22 to 270 μs in fluid solution and from 44 to 3440 μs in glass at 77 K. To our knowledge, these excited-state lifetimes are the longest reported for Ru(II)-based dyads containing only one organic chromophore and lacking terminal diimine groups. These excited states proved to be extremely sensitive to trace amounts of oxygen, owing to their long lifetimes and very low radiative rates. Herein, we demonstrate that (3)IL states of this nature are potent photodynamic agents, exhibiting the largest photocytotoxicity indices reported to date with nanomolar light cytotoxicities at very short drug-to-light intervals. Importantly, these new agents are robust enough to maintain submicromolar PDT in pigmented metastatic melanoma cells, where the presence of melanin in combination with low oxygen tension is known to compromise PDT. This activity underscores the potential of metal-organic PDT as an alternate treatment strategy for challenging environments such as malignant melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ru(II) polypyridine complexes: photophysics, photochemistry, eletrochemistry, and chemiluminescence
Juris, A., Balzani, V., Barigelletti, F., Campagna, S., Belser, P., & von Zelewsky, A. (1988) · Coordination Chemistry Reviews · doi:10.1016/0010-8545(88)80032-8 · Cited by 4,862
Final Version of 2009 AJCC Melanoma Staging and Classification
Balch, C. M., Gershenwald, J. E., Soong, S.-J., Thompson, J. F., Atkins, M. B., Byrd, D. R., Buzaid, A. C., Cochran, A. J., Coit, D. G., Ding, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4799 · Cited by 4,602
Photosensitized singlet oxygen and its applications
DeRosa, M. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00034-6 · Cited by 2,931
Mixed phosphine 2,2'-bipyridine complexes of ruthenium
Sullivan, B. P., Salmon, D. J., & Meyer, T. J. (1978) · Inorganic Chemistry · doi:10.1021/ic50190a006 · Cited by 1,723
Photophysics and photochemistry of photodynamic therapy: fundamental aspects
Plaetzer, K., Krammer, B., Berlanda, J., Berr, F., & Kiesslich, T. (2009) · Lasers in Medical Science · doi:10.1007/s10103-008-0539-1 · Cited by 891
Robbins Pathologic Basis of Disease
Morrison, A. B. (1999) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.282.18.1776-a · Cited by 668
Strained Ruthenium Complexes Are Potent Light-Activated Anticancer Agents
Howerton, B. S., Heidary, D. K., & Glazer, E. C. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3009677 · Cited by 498
Platinum Diimine Bis(acetylide) Complexes: Synthesis, Characterization, and Luminescence Properties
Hissler, M., Connick, W. B., Geiger, D. K., McGarrah, J. E., Lipa, D., Lachicotte, R. J., & Eisenberg, R. (2000) · Inorganic Chemistry · doi:10.1021/ic991250n · Cited by 418
Wachter, E., Heidary, D. K., Howerton, B. S., Parkin, S., & Glazer, E. C. (2012) · Chemical Communications · doi:10.1039/c2cc33359g · Cited by 317
McClenaghan, N. D., Leydet, Y., Maubert, B., Indelli, M. T., & Campagna, S. (2005) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2004.12.017 · Cited by 252
Current concepts of metastasis in melanoma
Zbytek, B., Carlson, J. A., Granese, J., Ross, J., Mihm, M., & Slominski, A. (2008) · Expert Review of Dermatology · doi:10.1586/17469872.3.5.569 · Cited by 242
Ji, S., Wu, W., Wu, W., Song, P., Han, K., Wang, Z., Liu, S., Guo, H., & Zhao, J. (2010) · Journal of Materials Chemistry · doi:10.1039/b916468e · Cited by 201
Hissler, M., Harriman, A., Khatyr, A., & Ziessel, R. F. (1999) · Chemistry - A European Journal · doi:10.1002/(sici)1521-3765(19991105)5:11<3366::aid-chem3366>3.0.co;2-i · Cited by 191
BRAF as therapeutic target in melanoma
Wellbrock, C., & Hurlstone, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.019 · Cited by 178
Chen, K. G., Valencia, J. C., Gillet, J., Hearing, V. J., & Gottesman, M. M. (2009) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2009.00630.x · Cited by 162
Galoppini, E., Guo, W., Zhang, W., Hoertz, P. G., Qu, P., & Meyer, G. J. (2002) · Journal of the American Chemical Society · doi:10.1021/ja025840n · Cited by 158
Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy
Brożyna, A. A., VanMiddlesworth, L., & Slominski, A. T. (2008) · International Journal of Cancer · doi:10.1002/ijc.23664 · Cited by 141
Photodynamic therapy in melanoma--an update.
Bâldea, I., & Filip, G. A. (2012) · PubMed · Cited by 130
Combating melanoma: The use of photodynamic therapy as a novel, adjuvant therapeutic tool
Davids, L. M., & Kleemann, B. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.11.007 · Cited by 126
Biophysical Aspects of Photodynamic Therapy
Juzeniene, A., Nielsen, K. P., & Moan, J. E. (2006) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.v25.i1-2.20 · Cited by 124
Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy
Mróz, P., Huang, Y., Szokalska, A., Zhiyentayev, T., Janjua, S., Nifli, A., Sherwood, M. E., Ruzié, C., Borbas, K. E., Fan, D., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-152587 · Cited by 107
Photosensitized generation of singlet oxygen from ruthenium(ii) and osmium(ii) bipyridyl complexes
Abdel‐Shafi, A. A., Worrall, D. R., & Ershov, A. Y. (2003) · Dalton Transactions · doi:10.1039/b310238f · Cited by 94
Palmisano, I., Bagnato, P., Palmigiano, A., Innamorati, G., Rotondo, G., Altimare, D., Venturi, C. B., Sviderskaya, E. V., Piccirillo, R., Coppola, M., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn241 · Cited by 88
Monro, S. M. A., Scott, J., Chouai, A., Lincoln, R., Zong, R., Thummel, R. P., & McFarland, S. A. (2010) · Inorganic Chemistry · doi:10.1021/ic902427r · Cited by 82
Self-citationFluctuations inpO2in Irradiated Human Melanoma Xenografts
Brurberg, K. G., Thuen, M., Ruud, E. M., & Rofstad, E. K. (2006) · Radiation Research · doi:10.1667/rr3491.1 · Cited by 50
Photodynamic Therapy of Human Malignant Melanoma Xenografts in Athymic Nude Mice1
Nelson, J. S., McCullough, J. L., & Berns, M. W. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.1.56 · Cited by 48
Abdel‐Shafi, A. A., Beer, P. D., Mortimer, R. J., & Wilkinson, F. (2000) · Physical Chemistry Chemical Physics · doi:10.1039/b002884n · Cited by 46
Cited by
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Monro, S., Colón, K. L., Yin, H., Roque, J., Konda, P., Gujar, S., Thummel, R. P., Lilge, L., Cameron, C. G., & McFarland, S. A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00211 · Cited by 1,461
Self-citationZhao, X., Liu, J., Fan, J., Chao, H., & Peng, X. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00173b · Cited by 1,270
Zeng, L., Gupta, P., Chen, Y., Wang, E., Ji, L., Chao, H., & Chen, Z.-S. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00195a · Cited by 1,017
The triplet excited state of Bodipy: formation, modulation and application
Zhao, J., Xu, K., Yang, W., Wang, Z., & Zhong, F. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00364d · Cited by 867
Metadata
- Authors
- Lincoln, R., Kohler, L., Monro, S., Yin, H., Stephenson, M., Zong, R., Chouai, A., Dorsey, C., Hennigar, R., Thummel, R. P., & McFarland, S. A.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-11-04
- Volume
- 135
- Issue
- 45
- Pages
- 17161-17175
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2328885231
- Cited by
- 297
- References
- 27
- FWCI
- 18.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.